InVivo Therapeutics Corp Est. EPS Q / Q
¿Qué es el Est. EPS Q / Q de InVivo Therapeutics Corp?
El Est. EPS Q / Q de InVivo Therapeutics Holdings Corp es -35.71%
¿Cuál es la definición de Est. EPS Q / Q?
La tasa de crecimiento prospectiva trimestral del EPS, año tras año, es el aumento estimado del EPS de la compañía para el próximo trimestre en comparación con el comportamiento de un trimestre correspondiente anterior.
The prospective EPS growth rate is a predicted estimate of the earnings per share growth rate towards the current quarter and expressed as a percentage compared to the respective past quarter. The estimated earnings per share growth rate is an important factor for judging a company's value. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
Est. EPS Q / Q de compañías en Sector Health Care en NASDAQ en comparadas con InVivo Therapeutics Corp
¿Qué hace InVivo Therapeutics Corp?
about invivo therapeutics invivo therapeutics holdings corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. the company was founded in 2005 with proprietary technology co-invented by robert langer, sc.d., professor at massachusetts institute of technology, and joseph p. vacanti, m.d., who then was at boston children’s hospital and who now is affiliated with massachusetts general hospital. in 2011, the company earned the david s. apple award from the american spinal injury association for its outstanding contribution to spinal cord injury medicine. in 2015, the company’s investigational neuro-spinal scaffold received the 2015 becker’s healthcare spine device award. the publicly-traded company is headquartered in cambridge, ma. for more details, visit www.invivotherapeutics.com. about the neuro-spinal scaffold™ following acute spinal cord injury, surgical implantation of the biodegradable neuro-spinal scaffold wi
Empresas con est. eps q / q similar a InVivo Therapeutics Corp
- Chiasma Inc tiene Est. EPS Q / Q de -36.00%
- Tide Water Oil Co. (India) tiene Est. EPS Q / Q de -35.86%
- Fresenius Medical Care AG tiene Est. EPS Q / Q de -35.85%
- Exelon tiene Est. EPS Q / Q de -35.78%
- Exelon tiene Est. EPS Q / Q de -35.78%
- Mallinckrodt Plc tiene Est. EPS Q / Q de -35.75%
- InVivo Therapeutics Corp tiene Est. EPS Q / Q de -35.71%
- Calithera Biosciences Inc tiene Est. EPS Q / Q de -35.67%
- Allstate Corp tiene Est. EPS Q / Q de -35.64%
- DarioHealth Corp tiene Est. EPS Q / Q de -35.59%
- Perdoceo Education tiene Est. EPS Q / Q de -35.56%
- Aeglea BioTherapeutics Inc tiene Est. EPS Q / Q de -35.48%
- BioNTech SE tiene Est. EPS Q / Q de -35.42%